207 related articles for article (PubMed ID: 38599171)
21. Targeting innate immunity for neurodegenerative disorders of the central nervous system.
Andreasson KI; Bachstetter AD; Colonna M; Ginhoux F; Holmes C; Lamb B; Landreth G; Lee DC; Low D; Lynch MA; Monsonego A; O'Banion MK; Pekny M; Puschmann T; Russek-Blum N; Sandusky LA; Selenica ML; Takata K; Teeling J; Town T; Van Eldik LJ
J Neurochem; 2016 Sep; 138(5):653-93. PubMed ID: 27248001
[TBL] [Abstract][Full Text] [Related]
22. Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases.
Aman Y; Ryan B; Torsetnes SB; Knapskog AB; Watne LO; McEwan WA; Fang EF
Int Rev Neurobiol; 2020; 155():169-202. PubMed ID: 32854854
[TBL] [Abstract][Full Text] [Related]
23. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.
Noori A; Mezlini AM; Hyman BT; Serrano-Pozo A; Das S
Neurobiol Dis; 2021 Feb; 149():105225. PubMed ID: 33347974
[TBL] [Abstract][Full Text] [Related]
24. ROS-Induced mtDNA Release: The Emerging Messenger for Communication between Neurons and Innate Immune Cells during Neurodegenerative Disorder Progression.
Zhao Y; Liu B; Xu L; Yu S; Fu J; Wang J; Yan X; Su J
Antioxidants (Basel); 2021 Nov; 10(12):. PubMed ID: 34943020
[TBL] [Abstract][Full Text] [Related]
25. Advances in lung ischemia/reperfusion injury: unraveling the role of innate immunity.
Li Q; Nie H
Inflamm Res; 2024 Mar; 73(3):393-405. PubMed ID: 38265687
[TBL] [Abstract][Full Text] [Related]
26. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Haukedal H; Freude K
J Mol Biol; 2019 Apr; 431(9):1818-1829. PubMed ID: 30763568
[TBL] [Abstract][Full Text] [Related]
27. Intracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics.
Kaur J; Singh H; Naqvi S
Mol Neurobiol; 2023 Jul; 60(7):3600-3616. PubMed ID: 36859688
[TBL] [Abstract][Full Text] [Related]
28. Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases.
Fakhoury M
Neurodegener Dis; 2015; 15(2):63-9. PubMed ID: 25591815
[TBL] [Abstract][Full Text] [Related]
29. Innate immune receptors in platelets and platelet-leukocyte interactions.
Dib PRB; Quirino-Teixeira AC; Merij LB; Pinheiro MBM; Rozini SV; Andrade FB; Hottz ED
J Leukoc Biol; 2020 Oct; 108(4):1157-1182. PubMed ID: 32779243
[TBL] [Abstract][Full Text] [Related]
30. Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice.
Szego EM; Malz L; Bernhardt N; Rösen-Wolff A; Falkenburger BH; Luksch H
Elife; 2022 Oct; 11():. PubMed ID: 36314770
[TBL] [Abstract][Full Text] [Related]
31. Danger-associated molecular patterns in Alzheimer's disease.
Venegas C; Heneka MT
J Leukoc Biol; 2017 Jan; 101(1):87-98. PubMed ID: 28049142
[TBL] [Abstract][Full Text] [Related]
32. A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
Gendelman HE; Mosley RL
J Neuroimmune Pharmacol; 2015 Dec; 10(4):645-50. PubMed ID: 26520433
[TBL] [Abstract][Full Text] [Related]
33. Differential contribution of microglia and monocytes in neurodegenerative diseases.
Baufeld C; O'Loughlin E; Calcagno N; Madore C; Butovsky O
J Neural Transm (Vienna); 2018 May; 125(5):809-826. PubMed ID: 29063348
[TBL] [Abstract][Full Text] [Related]
34. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
[TBL] [Abstract][Full Text] [Related]
35. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets.
Gao C; Jiang J; Tan Y; Chen S
Signal Transduct Target Ther; 2023 Sep; 8(1):359. PubMed ID: 37735487
[TBL] [Abstract][Full Text] [Related]
36. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration.
Peixoto CA; Oliveira WH; Araújo SMDR; Nunes AKS
Exp Neurol; 2017 Dec; 298(Pt A):31-41. PubMed ID: 28844606
[TBL] [Abstract][Full Text] [Related]
37. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
38. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.
Malaspina A; Puentes F; Amor S
Int Immunol; 2015 Mar; 27(3):117-29. PubMed ID: 25344935
[TBL] [Abstract][Full Text] [Related]
39. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
[TBL] [Abstract][Full Text] [Related]
40. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors.
Salminen A; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T
Prog Neurobiol; 2009 Feb; 87(3):181-94. PubMed ID: 19388207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
